卫宁健康
(300253)
| 流通市值：124.63亿 | | | 总市值：147.93亿 |
| 流通股本：18.55亿 | | | 总股本：22.01亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,482,174,028.84 | 994,411,309.05 | 397,456,279.95 | 2,106,166,908.59 |
| 营业总成本 | 1,749,247,317.63 | 1,139,874,224.5 | 464,227,086.2 | 2,323,174,988.34 |
| 其他经营收益 | | | | |
| 营业利润 | -313,859,424.69 | -228,738,499.77 | -13,352,006.55 | -418,139,654.64 |
| 利润总额 | -315,017,825.19 | -228,933,531.66 | -13,435,964.37 | -442,476,712.77 |
| 净利润 | -263,898,412.33 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -263,898,412.33 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 4,521,872,965.4 | 4,606,731,573.23 | 4,725,268,693.31 | 4,924,889,057.71 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,599,650,757.14 | 3,592,029,667.58 | 3,576,865,080.78 | 3,598,272,295.84 |
| 资产总计 | 8,121,523,722.54 | 8,198,761,240.81 | 8,302,133,774.09 | 8,523,161,353.55 |
| 流动负债: | | | | |
| 流动负债合计 | 2,586,059,705.54 | 2,648,694,384.2 | 1,508,241,077.81 | 1,739,667,978.17 |
| 非流动负债: | | | | |
| 非流动负债合计 | 86,629,232.39 | 81,055,144.44 | 1,202,967,700.44 | 1,187,948,052.19 |
| 负债合计 | 2,672,688,937.93 | 2,729,749,528.64 | 2,711,208,778.25 | 2,927,616,030.36 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,468,494,503.85 | 5,482,442,551.32 | 5,600,386,756.89 | 5,586,353,595.57 |
| 股东权益合计 | 5,448,834,784.61 | 5,469,011,712.17 | 5,590,924,995.84 | 5,595,545,323.19 |
| 负债和股东权益合计 | 8,121,523,722.54 | 8,198,761,240.81 | 8,302,133,774.09 | 8,523,161,353.55 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,885,522,943.63 | 1,217,239,326.98 | 593,133,232.15 | 3,712,262,008.7 |
| 经营活动现金流出小计 | 1,878,714,446.77 | 1,202,148,618.63 | 641,829,595.84 | 3,156,896,488.88 |
| 经营活动产生的现金流量净额 | 6,808,496.86 | 15,090,708.35 | -48,696,363.69 | 555,365,519.82 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 8,109,119.06 | 8,058,577.03 | 4,575,656.79 | 5,076,022.27 |
| 投资活动现金流出小计 | 117,247,501.05 | 78,123,106.37 | 36,701,031.21 | 247,992,252.73 |
| 投资活动产生的现金流量净额 | -109,138,381.99 | -70,064,529.34 | -32,125,374.42 | -242,916,230.46 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 9,254,931.87 | 6,324,931.64 | 2,659,730.98 | 167,842,334.56 |
| 筹资活动现金流出小计 | 115,886,416.27 | 96,731,278.06 | 44,404,456.34 | 97,745,619.24 |
| 筹资活动产生的现金流量净额 | -106,631,484.4 | -90,406,346.42 | -41,744,725.36 | 70,096,715.32 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | -0.09 |
| 现金及现金等价物净增加额 | -208,961,369.53 | -145,380,167.41 | -122,566,463.47 | 382,546,004.59 |
| 期末现金及现金等价物余额 | 1,446,126,459.67 | 1,509,707,661.79 | 1,532,521,365.73 | 1,655,087,829.2 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -145,380,167.41 | - | 382,546,004.59 |
最新报告期：2026-10-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华泰证券 | 范昳蕊 | 0.02 | 0.10 | 0.18 | 2026-10-28 |
| 华泰证券 | 范昳蕊 | 0.02 | 0.10 | 0.18 | 2026-08-26 |